The building will serve to bring together at the Roche site as many as possible of the employees who are presently spread across the city of Basel. Building 2 is expected to be ready for ...

Oct. 22 (Bloomberg) — Roche Holding AG plans to invest 3 billion Swiss francs ($3.2 billion) at its Basel headquarters over the next decade as the world’s biggest maker of cancer drugs updates ...

Drugmaker Roche <ROG.VX> is spending billions of dollars constructing the two tallest buildings in Switzerland for its global HQ, a vote of confidence in its Swiss base despite uncertainty ...

Roche plans to spend around $3bn updating and expanding its Basal site, home to the Swiss company’s headquarters, over the next 10 years. The company is set to build a new R&D centre for 1,900 ...

Herzog & de Meuron (HdM) has designed a new research facility for Roche, a large Swiss pharmaceutical company based in Basel. The four new structures, collectively known as pRED, consist of two ...

Roche said today it will spend CHF 3 billion ($3.15 billion) over the next 10 years on enhancements to its headquarters site in Basel, Switzerland. The pharma giant plans to construct a new R&D ...

Roche Holding AG plans to invest 3 billion Swiss francs ($3.2 billion) at its Basel headquarters over the next decade as the world’s biggest maker of cancer drugs updates its research and office ...

Over the next 10 years, Roche will invest 3 billion Swiss francs in the construction of a new research and development centre for around 1,900 employees, in a state-of-the-art office building for ...

Drugmaker Roche (ROG.VX) is spending billions of dollars constructing the two tallest buildings in Switzerland for its global HQ, a vote of confidence in its Swiss base despite uncertainty over the ...

Roche has presented development plans for its Basel site. Over the next 10 years, Roche will invest 3 billion Swiss francs in the construction of a new research and development centre for around 1,900 ...